...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of vitreoretinal diseases. >Intravitreal Injections Among Medicare Part B Beneficiaries, 2012-2016
【24h】

Intravitreal Injections Among Medicare Part B Beneficiaries, 2012-2016

机译：医疗保险B部分中Intravitreal注射受益者,2012 - 2016

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: Intravitreal injection therapy (IVIT) has transformed the management of many chorioretinal diseases. Although these treatments are effective, they can also be expensive. Using the Medicare Provider and Utilization Data Report (MPUDR), we aim to quantify the costs of these drugs to Medicare and to project future cost trends. Methods: Data were harvested from the MPUDR for all ophthalmology providers who delivered intravitreal injections (IVT) (CPT code 67028) during the years 2012-2016. Linear regression utilizing the MPUDR data was used to analyze cost trends and to project Medicare costs out to year 2026. Results: From 2012 to 2016, the total number of IVTs increased from 2?286?593 to 2?936?274 ( R ~(2)= 0.98; P = .001). The per-beneficiary Medicare cost rose significantly from $3,148 to $3,945 ( R ~(2)= 0.92; P = .03). The total cost to Medicare for IVIT increased from $1.68 billion to $2.73 billion ( R ~(2)= 0.99; P < .005). IVIT accounts for 37% of all ophthalmology Medicare reimbursements. At the current rate, IVIT costs will exceed $5 billion per year by 2026. Conclusions: The total number of injections and costs for IVIT rose significantly from 2012 to 2016. At the current rate, Medicare reimbursement for brand-name drugs will make up a large proportion of future costs.
机译：目的:Intravitreal注射疗法(IVIT)改变了许多脉络膜的管理疾病。有效,他们也可以是昂贵的。医疗保险提供者和利用数据报告(MPUDR),我们的目标是量化的成本药物医疗保险和以项目未来的成本的趋势。MPUDR眼科供应商交付intravitreal注射(溶)(CPT代码67028)在2012年- 2016年。回归利用MPUDR数据被用来分析项目成本趋势和医疗保险费用2026年。IVTs总数增加至2 ? 286 ?936年2 ? ?每个受益人的医疗保险成本大幅上涨从3148美元到3945美元(R ~ (2) = 0.92;总成本为IVIT增加医疗保险从16.8亿美元到27.3亿美元(R ~ (2) =0.99;眼科医疗保险补偿。现在的速度,IVIT成本将超过50亿美元到2026年每年。IVIT注射和成本上升从2012年到2016年。率,为品牌药物医疗保险报销将使未来成本的很大一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号